These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 17635240)
1. High levels of serum prostate-specific antigen due to PSA producing follicular non-Hodgkin's lymphoma. Oosterheert JJ; Budel LM; Vos P; Wittebol S Eur J Haematol; 2007 Aug; 79(2):155-8. PubMed ID: 17635240 [TBL] [Abstract][Full Text] [Related]
2. Do changes in a high serum prostate-specific antigen level and the free/total prostate-specific antigen ratio after antibiotic treatment rule out biopsy and the suspicion of cancer? Dirim A; Tekin MI; Koyluoglu E; Oguzulgen AI; Peskircioglu L; Ozkardes H Urol Int; 2009; 82(3):266-9. PubMed ID: 19440011 [TBL] [Abstract][Full Text] [Related]
3. Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound. Cirillo S; Petracchini M; D'Urso L; Dellamonica P; Illing R; Regge D; Muto G BJU Int; 2008 Aug; 102(4):452-8. PubMed ID: 18476973 [TBL] [Abstract][Full Text] [Related]
4. Age specific reference levels of serum prostate-specific antigen, prostate volume and prostate specific antigen density in healthy Iranian men. Khezri AA; Shirazi M; Ayatollahi SM; Lotfi M; Askarian M; Ariafar A; Afrasiabi MA Iran J Immunol; 2009 Mar; 6(1):40-8. PubMed ID: 19293477 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of prostate cancer at different levels of serum prostate-specific antigen (PSA) and different free: total PSA ratios in a consecutive series of men referred for prostate biopsies. Rydén L; Egevad L; Ekman P; Hellström M Scand J Urol Nephrol; 2007; 41(4):302-7. PubMed ID: 17763221 [TBL] [Abstract][Full Text] [Related]
7. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men. Ghafoori M; Varedi P; Hosseini SJ; Asgari M; Shakiba M Urol J; 2009; 6(3):182-8. PubMed ID: 19711272 [TBL] [Abstract][Full Text] [Related]
8. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate. Sheridan T; Herawi M; Epstein JI; Illei PB Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190 [TBL] [Abstract][Full Text] [Related]
9. [First results of PET / CT-guided secondary lymph node surgery on patients with a PSA relapse after radical prostatectomy]. Winter A; Uphoff J; Henke RP; Wawroschek F Aktuelle Urol; 2009 Sep; 40(5):294-9. PubMed ID: 19533582 [TBL] [Abstract][Full Text] [Related]
10. [Differentiation of prostate cancer from benign prostatic disease by total prostate specific antigen dynamic profiles after transrectal prostate biopsy]. Shao Q; Song J; Zhou ZJ; Du LD Zhonghua Nan Ke Xue; 2008 Jul; 14(7):597-601. PubMed ID: 18686378 [TBL] [Abstract][Full Text] [Related]
11. [The detection rate of prostate cancer in different prostate-specific antigen (PSA) levels in Chinese men]. Li M; Na YQ Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):16-8. PubMed ID: 18346372 [TBL] [Abstract][Full Text] [Related]
12. Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study. Kumar R; Nayyar R; Kumar V; Gupta NP; Hemal AK; Jagannathan NR; Dattagupta S; Thulkar S Urology; 2008 Oct; 72(4):859-63. PubMed ID: 18329078 [TBL] [Abstract][Full Text] [Related]
13. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases. Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175 [TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced gray-scale transrectal ultrasound-guided prostate biopsy in men with elevated serum prostate-specific antigen levels. Yang JC; Tang J; Li J; Luo Y; Li Y; Shi H Acad Radiol; 2008 Oct; 15(10):1291-7. PubMed ID: 18790401 [TBL] [Abstract][Full Text] [Related]
15. [The assessment of pathological PSA values by the general practitioner--observation or intervention?]. Braun KP; Brookman-Amissah S; May M; Grassmel Y; Hoschke B; Braun V Aktuelle Urol; 2009 May; 40(3):171-4. PubMed ID: 19479670 [TBL] [Abstract][Full Text] [Related]
16. Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection. Chiang IN; Chang SJ; Pu YS; Huang KH; Yu HJ; Huang CY Urol Int; 2009; 82(3):270-5. PubMed ID: 19440012 [TBL] [Abstract][Full Text] [Related]
17. False-positive serum prostate-specific antigen values in a patient with non-Hodgkin lymphoma of the kidney. Djavan B; Keffer JH; Molberg K; Roehrborn CG Urology; 1995 May; 45(5):875-8. PubMed ID: 7538247 [TBL] [Abstract][Full Text] [Related]
18. Detection rate of prostate cancer according to prostate-specific antigen and digital rectal examination in Korean men: a nationwide multicenter study. Seo HK; Chung MK; Ryu SB; Lee KH; Urology; 2007 Dec; 70(6):1109-12. PubMed ID: 18158028 [TBL] [Abstract][Full Text] [Related]
19. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men. Culp S; Porter M BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868 [TBL] [Abstract][Full Text] [Related]
20. The antibody response to Propionibacterium acnes is an independent predictor of serum prostate-specific antigen levels in biopsy-negative men. Shannon BA; Cohen RJ; Garrett KL BJU Int; 2008 Feb; 101(4):429-35. PubMed ID: 17850358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]